ARTIS Ventures

ARTIS Ventures is a San Francisco-based venture capital firm that finances and supports companies across stages in North America. The firm targets opportunities in consumer goods, healthcare, and related technologies, and its portfolio approach covers the full life cycle from initial investment to potential public offering and beyond. Its investment scope encompasses advanced technology sectors such as artificial intelligence, machine learning, quantum computing, smart data, engineering, diagnostics, targeted therapeutics, medical devices, and wellness, indicating a broad tech-enabled focus across industries.

Henry Klingenstein

Partner

Niraj Mehta

Associate

Stuart Peterson

Founder and General Partner

116 past transactions

Delfina

Series A in 2025
Delfina is a data-driven prenatal care platform that personalizes pregnancy care to improve safety for mothers and babies. It uses a data-powered approach to uncover insights in prenatal care and to optimize interventional workflows through machine learning models. The platform creates individualized pregnancy care plans based on patient risk assessed from multiple metrics and supports early intervention, helping providers deliver equitable, cost-effective care. By integrating data across clinical, demographic, and monitoring inputs, Delfina aims to enhance decision-making, streamline workflows, and improve outcomes throughout pregnancy.

Conceivable Life Sciences

Series A in 2025
Conceivable Life Sciences is developing an AI-powered automated IVF lab to increase accessibility to in vitro fertilization.

Second Front Systems

Series C in 2024
Second Front Systems develops software that facilitates government access to innovative commercial technologies for national security missions. Its flagship product, Atlas Fulcrum, enables identification, assessment, and secure deployment of these technologies. The company also offers program management services and High Technology Council, an enterprise consortium fostering collaboration between market players.

Luminate Medical

Venture Round in 2024
Luminate Medical specializes in developing innovative medical devices aimed at preventing hair loss during chemotherapy. Recognizing the significant impact of hair loss on patients' self-esteem, the company focuses on utilizing advanced medical technology to protect this essential element of personality.

Rad AI

Series B in 2024
Rad AI develops an artificial intelligence platform that automates report generation for radiologists. Its solution integrates with existing workflows, automating repetitive tasks to enhance efficiency, reduce burnout, and improve patient care.

OverT Bio

Seed Round in 2024
OverT Bio is a biotechnology company focused on developing cell therapies for cancer treatment. The company specializes in identifying and creating novel genetic modifications that empower immune cells to navigate and overcome the obstacles posed by tumors. Through its innovative approach, OverT Bio aims to enhance the effectiveness and durability of immunotherapies, contributing to advancements in cancer identification and treatment within the healthcare sector.

Power Life Science

Series A in 2023
Power Life Science believes that every patient deserves the chance to participate in a life-changing clinical trial. Is backed by some of the best healthcare investors and operators with a range of experience across clinical research and biopharmaceuticals. We are a small team - each of us with our own personal story and motivation to make a difference in the lives of patients.

Unnatural Products

Series A in 2023
Unnatural Products Inc. is a biotechnology company based in Santa Cruz, California, focused on drug discovery through innovative technology. Founded in 2016, the company specializes in designing and developing a platform that utilizes artificial intelligence and computational biology techniques to create macrocyclic peptides. These peptides target intracellular protein interactions, addressing drug targets that are typically considered undruggable. By harnessing machine learning to optimize chemical synthesis, Unnatural Products aims to accelerate the drug discovery process, offering potential therapeutic strategies for a wide range of medical conditions. Through its unique approach, the company seeks to pioneer new treatments where traditional methods have fallen short.

Ozlo Sleep

Series A in 2023
Ozlo Sleep is a science-driven sleep and audio technology company that supports and simplifies sleep rituals for clinical benefits, without the use of medication.

Affect Therapeutics

Series A in 2023
Affect Therapeutics offers an integrated digital treatment program for drug and alcohol addiction via a mobile app. The program uses contingency management and other reward systems to encourage healthy behaviors and new habits, aiming to improve member retention and better outcomes.

Range Biotechnologies

Seed Round in 2023
Range Biotechnologies develops translational proteomics tools to enable personalized health by precisely measuring multiple proteins across numerous samples, delivering insights into the mechanisms of disease and their evolution over time to support healthcare professionals.

Siren Biotechnology

Seed Round in 2023
Siren Biotechnology is a biotech company focused on developing innovative cancer treatments through a unique platform that integrates AAV gene therapy with cytokine immunotherapy. By combining these two transformative therapeutic approaches, Siren aims to address significant challenges in cancer treatment, such as delivery, efficacy, and toxicity. This novel modality seeks to enhance the elimination of tumor cells while simultaneously stimulating anti-tumor immunity, thereby offering a promising new strategy for cancer therapy. Through this integrated approach, Siren Biotechnology aspires to advance the effectiveness of cancer treatments and improve patient outcomes.

Outpace Bio

Series A in 2023
Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety. It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacy and safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.

Affect Therapeutics

Series A in 2023
Affect Therapeutics offers an integrated digital treatment program for drug and alcohol addiction via a mobile app. The program uses contingency management and other reward systems to encourage healthy behaviors and new habits, aiming to improve member retention and better outcomes.

Second Front Systems

Series A in 2022
Second Front Systems develops software that facilitates government access to innovative commercial technologies for national security missions. Its flagship product, Atlas Fulcrum, enables identification, assessment, and secure deployment of these technologies. The company also offers program management services and High Technology Council, an enterprise consortium fostering collaboration between market players.

CURE: One app, all things health

Series A in 2022
CURE Group GmbH is a healthcare on-demand company with the vision to be the easiest access to healthcare services without leaving your home. Today, CURE works with a local pharmacy network and delivers medicine quickly and sustainably. CURE was founded in December 2021 by Ali El-Ali and Manuel Aberle in Berlin. CURE investors include Breega, Craft Ventures, Abstract Ventures, PiLabs, and J12 Ventures, with participation from J Ventures.

Network Bio

Pre Seed Round in 2022
Network Bio develops a platform that serves as a centralized repository for clinical and molecular data. This enables researchers to identify patterns and correlations, facilitating precision medicine approaches for common human diseases.

Power Life Science

Seed Round in 2022
Power Life Science believes that every patient deserves the chance to participate in a life-changing clinical trial. Is backed by some of the best healthcare investors and operators with a range of experience across clinical research and biopharmaceuticals. We are a small team - each of us with our own personal story and motivation to make a difference in the lives of patients.

Science

Seed Round in 2022
Science is a startup company that develops technologies for a range of serious unmet medical needs.

Replay

Seed Round in 2022
Replay is a genome writing company focused on advancing genomic medicine by reprogramming biological systems through the synthesis and delivery of large DNA constructs. The company aims to harness the potential of genome engineering to create innovative solutions in medicine, enhancing the ability to manipulate genetic material for therapeutic purposes. By developing technologies that enable precise DNA writing, Replay seeks to redefine the landscape of genetic research and its applications, ultimately contributing to improved health outcomes and the treatment of various diseases.

Cartography Biosciences

Series A in 2022
Cartography Biosciences specializes in developing precision cancer immunotherapies. It employs single-cell analysis to identify novel targets for Chimeric Antigen Receptor T-cell (CAR-T) therapies, aiming to enhance safety and efficacy.

Locus Biosciences

Series B in 2022
Locus Biosciences is a biotechnology company focused on developing a CRISPR-engineered precision antibacterial platform aimed at transforming the treatment of bacterial diseases. The company integrates the antibacterial capabilities of CRISPR-Cas3 technology with the effective and safe delivery of bacteriophages, which are viruses that specifically target bacteria. This innovative approach allows for rapid initiation of treatment by physicians, leading to improved medical outcomes for patients. Through its advanced platform, Locus Biosciences seeks to address the challenges posed by pathogenic bacteria in a precise and targeted manner.

Tessera Therapeutics

Series C in 2022
Tessera Therapeutics is an early-stage life sciences company focused on pioneering Gene Writing technology, which allows for the precise insertion of therapeutic messages into the human genome. This innovative approach aims to address diseases at their source by enabling both small and large genetic alterations. By building on recent advancements in gene therapy and gene editing, Tessera Therapeutics seeks to overcome existing limitations in these fields, enhancing their efficacy and reach. Founded by Flagship Pioneering, the company aspires to establish a new category in genetic medicine that can significantly improve patient outcomes and transform healthcare.

ONI

Series B in 2021
ONI specializes in super-resolution microscopy, making advanced imaging technology accessible to researchers worldwide. Its flagship product, the Nanoimager, offers easy access to techniques like dSTORM and PALM, enabling users to visualize molecules within living cells for enhanced biological research.

Cerebral

Series C in 2021
Cerebral Inc. is a mental health telemedicine company that offers an online membership platform designed to provide accessible and affordable mental health care. Founded in 2019 and headquartered in Walnut, California, Cerebral specializes in addressing conditions such as anxiety, depression, and insomnia. The platform enables users to engage in medication management, counseling, and therapy, while also facilitating regular assessments and video appointments with care counselors. Additionally, it provides ongoing check-ins and messaging support from assigned care managers, along with prescription services and medication delivery. By employing evidence-based guidelines, Cerebral aims to improve the overall mental-emotional health of its patients, making high-quality care more accessible to a broader audience.

Meomind

Pre Seed Round in 2021
Meomind is a developer of a mental health application aimed at making mental health care accessible to all individuals. The company's platform features a comprehensive library of pre-recorded therapy sessions that address a variety of mental health needs, enhancing psychological well-being through personalized therapy programs. By offering a digital solution, Meomind enables users to engage in therapy without the barriers typically associated with traditional in-person sessions. Additionally, the company provides customer support via email and phone, ensuring assistance is readily available for users seeking help.

Rad AI

Series A in 2021
Rad AI develops an artificial intelligence platform that automates report generation for radiologists. Its solution integrates with existing workflows, automating repetitive tasks to enhance efficiency, reduce burnout, and improve patient care.

MycoMedica Life Sciences

Series A in 2021
MycoMedica Life Sciences, founded by prominent mycologist Paul Stamets, is a life sciences company focused on developing therapeutic drugs derived from fungi to enhance human health. The company specializes in exploring the healing potential of the fungal genome, particularly in relation to psychiatric and neurological disorders. One of its key innovations, the Stamets Stack, combines unique ingredients not typically found together in nature to maximize the effectiveness of psilocybin for prevention and treatment. By studying various fungal species and their applications, MycoMedica aims to advance fungi-based drug development, ultimately benefiting both individuals and the planet.

Glyphic Biotechnologies

Seed Round in 2021
Glyphic Biotechnologies is a biotechnology company focused on developing an advanced protein sequencing platform that aims to enhance the understanding of human biology and diseases. Recognizing that while DNA offers valuable biological insights, it is proteins that provide critical information about bodily functions, Glyphic Biotechnologies is creating a next-generation sequencing technology. This innovative platform is designed to increase binding affinity and improve consistency, ultimately facilitating the creation of personalized and precision cancer vaccines for diverse patient populations. By enabling scientists and researchers to perform single-molecule, massively parallel protein sequencing, the company aims to support the development of novel therapeutics and diagnostics, paving the way for significant advancements in biomedical research and healthcare.

Cerebral

Series B in 2021
Cerebral Inc. is a mental health telemedicine company that offers an online membership platform designed to provide accessible and affordable mental health care. Founded in 2019 and headquartered in Walnut, California, Cerebral specializes in addressing conditions such as anxiety, depression, and insomnia. The platform enables users to engage in medication management, counseling, and therapy, while also facilitating regular assessments and video appointments with care counselors. Additionally, it provides ongoing check-ins and messaging support from assigned care managers, along with prescription services and medication delivery. By employing evidence-based guidelines, Cerebral aims to improve the overall mental-emotional health of its patients, making high-quality care more accessible to a broader audience.

Athena Club

Series A in 2021
Athena Club is a consumer goods company that designs and manufactures feminine care and personal wellness products. Its product range includes tampons, razor kits, shave foam, body wash, face wipes, multivitamins, and probiotics, among other essentials, with a focus on affordable, door-to-door delivery. The company emphasizes high-quality ingredients, sustainable packaging, and the incorporation of innovative patented technologies to improve personal care. Athena Club targets body, wellness, and period care needs for women and aims to provide convenient access to everyday self-care products.

ViaCyte

Series D in 2021
ViaCyte, Inc. is a regenerative medicine company based in San Diego, California, that specializes in developing cell replacement therapies for diabetes. The company’s primary product candidates, VC-01 and VC-02, aim to treat type 1 diabetes by implanting pancreatic beta-cell precursors derived from stem cells within an encapsulation device. This innovative approach allows the implanted cells to produce insulin in response to blood glucose levels while minimizing the risk of immune rejection, thereby eliminating the need for immunosuppressants. ViaCyte's goal is to provide a long-term solution that can free both type 1 and type 2 diabetes patients from dependence on insulin and reduce associated complications such as hypoglycemia and cardiovascular issues. Founded in 1999, ViaCyte was previously known as Novocell, Inc., and changed its name in 2010. The company also operates an additional facility in Athens, Georgia.

Seed Health

Series A in 2021
Seed Health is a biotechnology company focused on therapeutics, consumer health innovations, and environmental solutions grounded in microbial sciences. It collaborates with academic researchers to advance discoveries in microbiology and develops health supplements that employ live biotherapeutics, combining probiotics and prebiotics to support digestive health, skin health, heart health, and micronutrient synthesis.

Transparent Health Marketplace

Series C in 2021
Transparent Health Marketplace, Inc. is a company that operates an innovative online platform designed to facilitate the procurement and delivery of healthcare services within the workers' compensation sector. Founded in 2016 and headquartered in Wayne, Pennsylvania, Transparent Health Marketplace connects payors, including carriers and third-party administrators, with healthcare service providers in a marketplace model. This platform allows providers to set their own prices, ensuring market-driven pricing and swift payment for awarded contracts. By replacing traditional network contract models with its transparent marketplace approach, Transparent Health Marketplace aims to enhance the efficiency and effectiveness of care for injured workers, enabling them to receive the necessary healthcare services promptly.

Outpace Bio

Series A in 2021
Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety. It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacy and safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.

Excision BioTherapeutics

Venture Round in 2021
Excision BioTherapeutics Inc. is a life science company based in Philadelphia, Pennsylvania, established in 2015. The company is dedicated to the development and commercialization of gene editing therapeutics aimed at treating life-threatening diseases caused by neurotropic viruses. Utilizing CRISPR-based technology, Excision BioTherapeutics focuses on creating advanced gene-editing medicines that can eradicate or disrupt viral genes in human patients. The company's mission is to advance these therapeutics into safe and effective treatments, significantly improving the lives of individuals affected by viral infections globally.

Excision BioTherapeutics

Series A in 2021
Excision BioTherapeutics Inc. is a life science company based in Philadelphia, Pennsylvania, established in 2015. The company is dedicated to the development and commercialization of gene editing therapeutics aimed at treating life-threatening diseases caused by neurotropic viruses. Utilizing CRISPR-based technology, Excision BioTherapeutics focuses on creating advanced gene-editing medicines that can eradicate or disrupt viral genes in human patients. The company's mission is to advance these therapeutics into safe and effective treatments, significantly improving the lives of individuals affected by viral infections globally.

Second Front Systems

Funding Round in 2021
Second Front Systems develops software that facilitates government access to innovative commercial technologies for national security missions. Its flagship product, Atlas Fulcrum, enables identification, assessment, and secure deployment of these technologies. The company also offers program management services and High Technology Council, an enterprise consortium fostering collaboration between market players.

Eko Health

Series C in 2020
Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Climax Foods

Seed Round in 2020
Climax Foods Inc. is a plant-based food company based in Berkeley, California, that leverages artificial intelligence to create alternatives to animal-based products. Founded in 2019, Climax Foods employs a combination of data science, machine learning, and predictive modeling to enhance food innovation processes. The company's technology focuses on rapid experimentation to develop dairy alternatives that excel in taste, texture, nutrition, and cost-effectiveness. By optimizing these aspects, Climax Foods enables its clients to produce plant-based foods that can effectively compete with traditional animal-based options, aiming to transform the global food production system.

Replay

Seed Round in 2020
Replay is a genome writing company focused on advancing genomic medicine by reprogramming biological systems through the synthesis and delivery of large DNA constructs. The company aims to harness the potential of genome engineering to create innovative solutions in medicine, enhancing the ability to manipulate genetic material for therapeutic purposes. By developing technologies that enable precise DNA writing, Replay seeks to redefine the landscape of genetic research and its applications, ultimately contributing to improved health outcomes and the treatment of various diseases.

Lemonaid Health

Series B in 2020
Founded in 2013, Lemonaid Health specializes in improving patient experience through advanced machine learning and AI. It offers direct-to-consumer telemedicine services, utilizing evidence-based guidelines to provide affordable healthcare.

Activ Surgical

Venture Round in 2020
Activ Surgical Inc. is a digital surgery company based in Boston, Massachusetts, dedicated to enhancing surgical procedures through advanced technology. Established in 2014 and originally known as Omniboros Inc., the company specializes in developing a robotic surgery platform that integrates computer vision, artificial intelligence, and robotics. Its flagship product, the Smart Tissue Autonomous Robot (STAR), is designed to improve surgical efficiency, accuracy, and patient outcomes while reducing the risk of unintended complications. Activ Surgical's innovative, patent-protected surgical software facilitates augmented reality-based and AI-driven operations, thereby enhancing surgeons' intra-operative decision-making and fostering safer surgical practices.

Replay

Seed Round in 2020
Replay is a genome writing company focused on advancing genomic medicine by reprogramming biological systems through the synthesis and delivery of large DNA constructs. The company aims to harness the potential of genome engineering to create innovative solutions in medicine, enhancing the ability to manipulate genetic material for therapeutic purposes. By developing technologies that enable precise DNA writing, Replay seeks to redefine the landscape of genetic research and its applications, ultimately contributing to improved health outcomes and the treatment of various diseases.

Second Front Systems

Seed Round in 2020
Second Front Systems develops software that facilitates government access to innovative commercial technologies for national security missions. Its flagship product, Atlas Fulcrum, enables identification, assessment, and secure deployment of these technologies. The company also offers program management services and High Technology Council, an enterprise consortium fostering collaboration between market players.

Creator Cash

Seed Round in 2020
Creator Cash is a financial services platform designed specifically for social media creators. Founded in 2020 and headquartered in San Francisco, California, the company offers a range of financial products, including savings accounts and debit cards, tailored to the unique needs of content creators. In addition to traditional financial services, Creator Cash provides insights on earnings and revenue, assisting creators in managing their YouTube channels effectively. As a subsidiary of ChannelMeter, Inc., Creator Cash combines financial expertise with an understanding of the creator economy to support the financial well-being of its users.

TAE Life Sciences

Series B in 2020
TAE Life Sciences is a biotechnology company focused on biologically targeted radiation therapy based on Boron Neutron Capture Therapy (BNCT). It develops an accelerator-based neutron beam platform and a portfolio of targeted drug and neutron-technology solutions to enable next-generation combination cancer therapy as a first-line treatment for patients worldwide, including those with inoperable, invasive, or recurrent cancers that have limited options.

Idbydna

Series B in 2020
IDbyDNA, Inc. is a biotechnology company focused on developing metagenomics technologies for the precise identification of infectious diseases. Founded in 2014 and based in Salt Lake City, Utah, the company offers its proprietary platform, Explify, which aids laboratories in detecting pathogens through a streamlined workflow. IDbyDNA provides a range of testing services, including respiratory and research services, primarily catering to hospitals, reference labs, clinical research organizations, and the biopharmaceutical industry. By integrating computational biology and artificial intelligence into its offerings, the company enhances the accuracy of nucleic acid-based microorganism detection, enabling healthcare providers to deliver comprehensive infectious disease profiles. IDbyDNA aims to improve diagnostic and treatment practices in response to the growing challenge of infectious diseases, thereby reducing related morbidity and mortality.

Crediwatch

Series A in 2019
Crediwatch is an information intelligence platform that specializes in connecting business and financial data to deliver analytics-driven insights for effective decision-making. It allows businesses and lenders to integrate their private datasets, facilitating analysis of key companies relevant to their operations. By leveraging advanced computational techniques, including machine learning and natural language processing, Crediwatch transforms distributed and unstructured data into actionable insights. This enables financial institutions, corporations, and small to medium enterprises to make informed decisions, assess market opportunities, and manage risks effectively. As India’s first digital trust platform, Crediwatch is committed to supporting the growth of small and medium businesses by enhancing their access to critical financial insights.

Enklu

Seed Round in 2019
Enklu, Inc. is a company specializing in augmented reality (AR) technology, focused on transforming museums and galleries into interactive experiences akin to video games. It offers Enklu Cloud, a platform that enables users to create and edit mixed reality content in real-time, which can be accessed through the web or AR headsets like Microsoft HoloLens. Enklu serves as a three-sided marketplace that connects players, creators, and operators of location-based entertainment experiences. Originally founded as CreatAR Corp. in 2016, the company rebranded to Enklu, Inc. in February 2019 and is headquartered in Alameda, California.

Astra

Series C in 2019
Astra Space, Inc. is a technology company based in Alameda, California, that specializes in designing and building rockets for satellite delivery and launch services. Founded in 2004 and originally known as Ventions LLC, the company rebranded in 2016 and aims to provide accessible and affordable access to space. Astra offers online reservations for payload deliveries to both sun-synchronous and low inclination orbits, with a focus on dedicated launch services for payloads ranging from 50 kg to 150 kg. The business is divided into two segments: Launch Services, which provides rapid global launch capabilities, and Space Products, which includes the development of space products tailored to customer needs for successful satellite launches. Astra operates test facilities to support its operations and is committed to facilitating frequent access to space for satellite operators and governments.

Eko Health

Series B in 2019
Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Unnatural Products

Seed Round in 2019
Unnatural Products Inc. is a biotechnology company based in Santa Cruz, California, focused on drug discovery through innovative technology. Founded in 2016, the company specializes in designing and developing a platform that utilizes artificial intelligence and computational biology techniques to create macrocyclic peptides. These peptides target intracellular protein interactions, addressing drug targets that are typically considered undruggable. By harnessing machine learning to optimize chemical synthesis, Unnatural Products aims to accelerate the drug discovery process, offering potential therapeutic strategies for a wide range of medical conditions. Through its unique approach, the company seeks to pioneer new treatments where traditional methods have fallen short.

Food Is Good

Pre Seed Round in 2019
Food Is Good develops a mobile application, The Fig App, designed to help users manage their dietary needs and preferences. It enables users to scan barcodes and find foods that match their dietary restrictions or preferences, such as gluten-free or vegan options.

Roshi

Venture Round in 2019
Roshi Solutions, Inc. is a San Francisco-based company that specializes in developing software-as-a-service (SaaS) inventory management solutions tailored for the cannabis industry. Founded in 2018, Roshi's platform enables cannabis manufacturers and distributors to efficiently manage inventory, track orders, and oversee transportation services. The software provides tools for optimizing production planning and streamlining billing processes, ensuring that businesses can make informed, data-driven decisions to enhance their profitability. Additionally, Roshi emphasizes regulatory compliance by incorporating robust audit logs and real-time integration with compliance systems. By leveraging proprietary algorithms and predictive analytics, the platform enhances operational efficiency and maintains data integrity, bringing advanced supply chain management capabilities typically found in FDA-regulated industries to the cannabis sector.

Aether Bio

Seed Round in 2018
Aether Bio is a technology company that focuses on re-purposing enzymes to create new compounds using machine learning. By integrating machine learning with high-throughput robotic laboratories, Aether Bio engineers enzymes rapidly and enables massively parallelized experimentation. This innovative approach generates significantly larger datasets compared to competitors, allowing researchers to manufacture complex and novel products more efficiently and at a lower cost. The company's technology aims to provide healthcare institutions with sustainable and affordable chemicals and materials essential for their operations.

Quid

Series E in 2018
Quid, Inc. is a technology company based in San Francisco, California, with additional offices in New York and London. Founded in 2006, Quid develops a platform that enables users to search, analyze, and visualize collective intelligence derived from written language. Its software specializes in text-based data analysis, utilizing artificial intelligence and natural language processing to uncover insights from vast datasets, including patents, news articles, and blog posts. Quid's proprietary algorithms facilitate the identification of patterns and connections, allowing non-technical users in various sectors, such as marketing, consulting, technology, healthcare, and finance, to independently access and derive meaningful insights from high-value information. In January 2020, Quid merged with NetBase Solutions, forming a combined entity known as Netbase Quid.

HeatGen

Venture Round in 2018
HeatGen specializes in self-heating technology that transforms ordinary food packaging into self-heating containers. Its flameless thermal reaction enables safe, controlled heating of prepared foods or beverages on-the-go, serving various industries including food and food packaging.

TAE Life Sciences

Series A in 2018
TAE Life Sciences is a biotechnology company focused on biologically targeted radiation therapy based on Boron Neutron Capture Therapy (BNCT). It develops an accelerator-based neutron beam platform and a portfolio of targeted drug and neutron-technology solutions to enable next-generation combination cancer therapy as a first-line treatment for patients worldwide, including those with inoperable, invasive, or recurrent cancers that have limited options.

Eko Health

Series A in 2018
Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Locus Biosciences

Series A in 2017
Locus Biosciences is a biotechnology company focused on developing a CRISPR-engineered precision antibacterial platform aimed at transforming the treatment of bacterial diseases. The company integrates the antibacterial capabilities of CRISPR-Cas3 technology with the effective and safe delivery of bacteriophages, which are viruses that specifically target bacteria. This innovative approach allows for rapid initiation of treatment by physicians, leading to improved medical outcomes for patients. Through its advanced platform, Locus Biosciences seeks to address the challenges posed by pathogenic bacteria in a precise and targeted manner.

Excision BioTherapeutics

Seed Round in 2017
Excision BioTherapeutics Inc. is a life science company based in Philadelphia, Pennsylvania, established in 2015. The company is dedicated to the development and commercialization of gene editing therapeutics aimed at treating life-threatening diseases caused by neurotropic viruses. Utilizing CRISPR-based technology, Excision BioTherapeutics focuses on creating advanced gene-editing medicines that can eradicate or disrupt viral genes in human patients. The company's mission is to advance these therapeutics into safe and effective treatments, significantly improving the lives of individuals affected by viral infections globally.

Zenrez

Series A in 2017
Zenrez Corporation is a San Francisco-based company that operates a mobile application designed for booking gyms and fitness centers. Founded in 2014, Zenrez provides boutique fitness studios with advanced sales and marketing software centered around revenue management. The platform utilizes dynamic pricing and yield management techniques, traditionally employed by larger industries, to enhance revenue generation, foster repeat business, and minimize customer churn. Zenrez's promotional booking platform connects fitness enthusiasts with carefully curated local studios, allowing users to discover and reserve premium classes without the burden of monthly memberships or fees. Additionally, the company's CRM platform offers valuable insights into growth opportunities and actionable fitness-specific key performance indicators, enabling studios to optimize their acquisition and retention strategies effectively.

Versa Networks

Series C in 2016
Versa Networks, Inc. is a technology company specializing in software-defined networking (SDN) and cybersecurity solutions. Established in 2012 and headquartered in Santa Clara, California, with an additional office in Bengaluru, India, Versa focuses on providing integrated cloud, networking, and security services for enterprise and service provider customers. The company’s offerings include advanced secure access service edge (SASE) solutions that combine networking, security, and analytics, delivered through cloud, on-premises, or hybrid models. Versa's platform is designed for scalability, featuring genuine multitenancy and sophisticated management tools that help organizations optimize their wide area networks (WAN) and reduce infrastructure costs. With thousands of customers worldwide, Versa Networks is committed to simplifying and securing modern networks across a diverse range of environments.

Idbydna

Series A in 2016
IDbyDNA, Inc. is a biotechnology company focused on developing metagenomics technologies for the precise identification of infectious diseases. Founded in 2014 and based in Salt Lake City, Utah, the company offers its proprietary platform, Explify, which aids laboratories in detecting pathogens through a streamlined workflow. IDbyDNA provides a range of testing services, including respiratory and research services, primarily catering to hospitals, reference labs, clinical research organizations, and the biopharmaceutical industry. By integrating computational biology and artificial intelligence into its offerings, the company enhances the accuracy of nucleic acid-based microorganism detection, enabling healthcare providers to deliver comprehensive infectious disease profiles. IDbyDNA aims to improve diagnostic and treatment practices in response to the growing challenge of infectious diseases, thereby reducing related morbidity and mortality.

Zenrez

Seed Round in 2016
Zenrez Corporation is a San Francisco-based company that operates a mobile application designed for booking gyms and fitness centers. Founded in 2014, Zenrez provides boutique fitness studios with advanced sales and marketing software centered around revenue management. The platform utilizes dynamic pricing and yield management techniques, traditionally employed by larger industries, to enhance revenue generation, foster repeat business, and minimize customer churn. Zenrez's promotional booking platform connects fitness enthusiasts with carefully curated local studios, allowing users to discover and reserve premium classes without the burden of monthly memberships or fees. Additionally, the company's CRM platform offers valuable insights into growth opportunities and actionable fitness-specific key performance indicators, enabling studios to optimize their acquisition and retention strategies effectively.

Fabric Genomics (formerly Omicia)

Series B in 2016
Fabric Genomics is making genomics-driven precision medicine a reality. We provide clinical decision support software that enables clinical labs, hospital systems and country-sequencing programs to gain actionable genomic insights, resulting in faster and more accurate diagnoses and reduced turnaround time. Fabric’s end-to-end genomic analysis platform incorporates proven AI algorithms, and has applications in both hereditary disease and oncology. Headquartered in Oakland, California, Fabric Genomics was founded by industry veterans and innovators with a deep understanding of bioinformatics, large-scale genomics and clinical diagnostics.

Solazyme

Post in 2016
Solazyme is a synthetic biology company that specializes in converting algal biomass into biofuels. Solazyme not only creates biofuels for the the transportation industry, but is experimenting with ways to tailor its products for the cosmetic and food industries.

Zenrez

Seed Round in 2015
Zenrez Corporation is a San Francisco-based company that operates a mobile application designed for booking gyms and fitness centers. Founded in 2014, Zenrez provides boutique fitness studios with advanced sales and marketing software centered around revenue management. The platform utilizes dynamic pricing and yield management techniques, traditionally employed by larger industries, to enhance revenue generation, foster repeat business, and minimize customer churn. Zenrez's promotional booking platform connects fitness enthusiasts with carefully curated local studios, allowing users to discover and reserve premium classes without the burden of monthly memberships or fees. Additionally, the company's CRM platform offers valuable insights into growth opportunities and actionable fitness-specific key performance indicators, enabling studios to optimize their acquisition and retention strategies effectively.

Bracket Computing

Series C in 2015
Bracket Computing, based in Mountain View, California, develops software designed to enhance workload isolation and security for enterprises operating in hybrid cloud environments. The company's solution includes crypto-enforced micro-segmentation with always-on encryption of data at rest and in motion, utilizing customer-controlled keys. Additionally, it offers data and runtime integrity monitoring, along with auditability and forensic capabilities that capture memory during breaches. Founded in 2011, Bracket Computing aims to reimagine enterprise computing through radical innovation, providing a secure platform that empowers IT departments to maintain speed and agility while protecting against malware, malicious insiders, and operational errors.

Stemcentrx

Series G in 2015
Stemcentrx is a biotechnology company focused on developing innovative therapies aimed at curing cancer and improving patient survival rates. Founded in 2008 by Brian Slingerland and Scott J. Dylla, the company is headquartered in South San Francisco, California. Stemcentrx specializes in creating disease-specific treatments that target cancer stem cells, the cells responsible for initiating and sustaining tumor growth. This approach allows healthcare providers to more effectively address the root causes of cancer, enhancing the potential for successful outcomes for patients. In 2016, Stemcentrx became a subsidiary of AbbVie, further expanding its resources and capabilities in the fight against cancer.

Cohesity

Series B in 2015
Cohesity develops hyper-converged secondary storage solutions that consolidate, protect, and share non-mission-critical data assets of large organizations. Its platform, Cohesity DataPlatform, converges data protection infrastructure including backup, replication, disaster recovery, and cloud tiering. Additionally, it offers Cohesity Helios, a SaaS-based management solution for monitoring and managing secondary data and applications.

Stringify

Seed Round in 2015
Stringify is a technology company focused on creating a platform that integrates both physical and digital elements into a cohesive user experience. The platform is designed to facilitate the automation of Internet of Things (IoT) devices, allowing users to discover, design, and control various aspects of their lives seamlessly. Stringify's solution provides customers with convenient access to their connected devices without the need for additional hardware, streamlining the process of managing and interacting with the technology that matters most to them. Through its innovative approach, Stringify aims to enhance the way individuals experience and engage with their environments.

Quid

Series D in 2015
Quid, Inc. is a technology company based in San Francisco, California, with additional offices in New York and London. Founded in 2006, Quid develops a platform that enables users to search, analyze, and visualize collective intelligence derived from written language. Its software specializes in text-based data analysis, utilizing artificial intelligence and natural language processing to uncover insights from vast datasets, including patents, news articles, and blog posts. Quid's proprietary algorithms facilitate the identification of patterns and connections, allowing non-technical users in various sectors, such as marketing, consulting, technology, healthcare, and finance, to independently access and derive meaningful insights from high-value information. In January 2020, Quid merged with NetBase Solutions, forming a combined entity known as Netbase Quid.

ChefsFeed

Series A in 2015
ChefsFeed is a food media and technology platform that connects users with the culinary industry, offering dining and drinking inspiration, guides, and unique experiences from experts. The platform features an application that utilizes users' current locations to help them discover specific dishes, while also enabling culinary professionals to share recipes and restaurant reviews. By providing insights from experts, ChefsFeed helps diners make informed choices about what to eat. The company fosters collaboration between culinary professionals and leading brands, promoting innovative partnerships both online and in-person.

Kanjoya

Venture Round in 2015
Kanjoya, Inc. operates a workforce intelligence and management platform designed for enterprise companies. The company specializes in employee engagement solutions that allow organizations to capture feedback, analyze results in real-time, and distribute vital intelligence. Its key offerings include Kanjoya Perception, which assesses employee emotions, attitudes, and intentions while predicting behaviors; a Workday directory that facilitates employee surveys and performance reviews; and Perception for Performance, a tool that helps managers evaluate, reward, and motivate employees. By leveraging advanced artificial intelligence, natural language processing, and machine learning, Kanjoya provides insights into the motivations and emotions driving business outcomes. Founded in 2006 and based in San Francisco, California, Kanjoya was previously known as Experience Project, Inc. The company has been a subsidiary of The Ultimate Software Group, Inc. since September 2016.

Versa Networks

Series B in 2014
Versa Networks, Inc. is a technology company specializing in software-defined networking (SDN) and cybersecurity solutions. Established in 2012 and headquartered in Santa Clara, California, with an additional office in Bengaluru, India, Versa focuses on providing integrated cloud, networking, and security services for enterprise and service provider customers. The company’s offerings include advanced secure access service edge (SASE) solutions that combine networking, security, and analytics, delivered through cloud, on-premises, or hybrid models. Versa's platform is designed for scalability, featuring genuine multitenancy and sophisticated management tools that help organizations optimize their wide area networks (WAN) and reduce infrastructure costs. With thousands of customers worldwide, Versa Networks is committed to simplifying and securing modern networks across a diverse range of environments.

Palantir Technologies

Series I in 2014
Palantir Technologies develops data fusion, integration, and analytics software for public institutions, commercial enterprises, and non-profit organizations worldwide. The company offers Gotham, a platform that integrates, manages, secures, and analyzes enterprise data, and Metropolis, a platform that integrates, enriches, models, and analyzes quantitative data for commercial use. Palantir's software supports activities such as anti-fraud, crisis response, cyber security, defense, disaster preparedness, disease response, healthcare delivery, intelligence, law enforcement, insurance analytics, and pharmaceutical research. Its solutions enable collaboration across and within organizations to make sense of large and complex data sets. Palantir serves government, defense, finance, healthcare, and other industries. The company was founded in 2003 and is based in Palo Alto, California.

Stateless Networks

Series A in 2014
Stateless Networks Inc. specializes in providing performance infrastructure and networking solutions tailored for enterprises, service providers, and the federal government. Founded in 2012 and headquartered in San Francisco, the company develops innovative software such as the Stateless AutoWare SDN Fabric Manager, which enhances network management through server-class monitoring capabilities. This technology accelerates deployments, improves system resilience, automates administrative tasks, and facilitates rapid recovery after equipment failures. By leveraging a combination of deep network understanding and advanced distributed systems, Stateless Networks aims to transform network operations for software-centric environments. The company collaborates with leading network and infrastructure vendors to deliver solutions that optimize performance and visibility in enterprise data centers.

Tastemade

Series C in 2014
Tastemade, Inc. is a media company that specializes in producing and delivering content for a global community of food enthusiasts. Founded in 2012 and headquartered in Santa Monica, California, Tastemade offers a variety of themed shows, including video recipes and cooking programs, accessible through its YouTube channel and food channels across the Americas, Europe, and Asia. The company also features a mobile application for iPhone users, allowing them to discover, create, and share food-related videos. In addition, Tastemade provides online tutorials covering topics such as food photography, food styling, and video production techniques. With a focus on connecting people through food and travel, Tastemade aims to create engaging stories that resonate with audiences on digital and streaming platforms.

Modern Meadow

Series A in 2014
Founded in 2011, Modern Meadow is a biofabrication company based in Brooklyn, New York. It specializes in growing animal-free leather using living cells, aiming to provide sustainable alternatives without compromising performance.

Stateless Networks

Convertible Note in 2014
Stateless Networks Inc. specializes in providing performance infrastructure and networking solutions tailored for enterprises, service providers, and the federal government. Founded in 2012 and headquartered in San Francisco, the company develops innovative software such as the Stateless AutoWare SDN Fabric Manager, which enhances network management through server-class monitoring capabilities. This technology accelerates deployments, improves system resilience, automates administrative tasks, and facilitates rapid recovery after equipment failures. By leveraging a combination of deep network understanding and advanced distributed systems, Stateless Networks aims to transform network operations for software-centric environments. The company collaborates with leading network and infrastructure vendors to deliver solutions that optimize performance and visibility in enterprise data centers.

Stemcentrx

Series F in 2014
Stemcentrx is a biotechnology company focused on developing innovative therapies aimed at curing cancer and improving patient survival rates. Founded in 2008 by Brian Slingerland and Scott J. Dylla, the company is headquartered in South San Francisco, California. Stemcentrx specializes in creating disease-specific treatments that target cancer stem cells, the cells responsible for initiating and sustaining tumor growth. This approach allows healthcare providers to more effectively address the root causes of cancer, enhancing the potential for successful outcomes for patients. In 2016, Stemcentrx became a subsidiary of AbbVie, further expanding its resources and capabilities in the fight against cancer.

Bitnet

Convertible Note in 2014
Bitnet is a company that specializes in providing a digital commerce platform designed for enterprise-scale merchants to accept bitcoin payments. With a focus on online payment solutions, Bitnet's team comprises professionals with extensive experience in engineering, product development, and business management. The company is recognized for its significant contributions to the development and management of CyberSource, one of the largest payment gateways in the world, which was acquired by Visa for $2 billion in 2010. By facilitating bitcoin transactions, Bitnet aims to enhance the payment capabilities of large merchants and integrate cryptocurrency into mainstream commerce.

Fabric Genomics (formerly Omicia)

Series A in 2014
Fabric Genomics is making genomics-driven precision medicine a reality. We provide clinical decision support software that enables clinical labs, hospital systems and country-sequencing programs to gain actionable genomic insights, resulting in faster and more accurate diagnoses and reduced turnaround time. Fabric’s end-to-end genomic analysis platform incorporates proven AI algorithms, and has applications in both hereditary disease and oncology. Headquartered in Oakland, California, Fabric Genomics was founded by industry veterans and innovators with a deep understanding of bioinformatics, large-scale genomics and clinical diagnostics.

Bracket Computing

Series B in 2014
Bracket Computing, based in Mountain View, California, develops software designed to enhance workload isolation and security for enterprises operating in hybrid cloud environments. The company's solution includes crypto-enforced micro-segmentation with always-on encryption of data at rest and in motion, utilizing customer-controlled keys. Additionally, it offers data and runtime integrity monitoring, along with auditability and forensic capabilities that capture memory during breaches. Founded in 2011, Bracket Computing aims to reimagine enterprise computing through radical innovation, providing a secure platform that empowers IT departments to maintain speed and agility while protecting against malware, malicious insiders, and operational errors.

Quid

Convertible Note in 2013
Quid, Inc. is a technology company based in San Francisco, California, with additional offices in New York and London. Founded in 2006, Quid develops a platform that enables users to search, analyze, and visualize collective intelligence derived from written language. Its software specializes in text-based data analysis, utilizing artificial intelligence and natural language processing to uncover insights from vast datasets, including patents, news articles, and blog posts. Quid's proprietary algorithms facilitate the identification of patterns and connections, allowing non-technical users in various sectors, such as marketing, consulting, technology, healthcare, and finance, to independently access and derive meaningful insights from high-value information. In January 2020, Quid merged with NetBase Solutions, forming a combined entity known as Netbase Quid.

Palantir Technologies

Series H in 2013
Palantir Technologies develops data fusion, integration, and analytics software for public institutions, commercial enterprises, and non-profit organizations worldwide. The company offers Gotham, a platform that integrates, manages, secures, and analyzes enterprise data, and Metropolis, a platform that integrates, enriches, models, and analyzes quantitative data for commercial use. Palantir's software supports activities such as anti-fraud, crisis response, cyber security, defense, disaster preparedness, disease response, healthcare delivery, intelligence, law enforcement, insurance analytics, and pharmaceutical research. Its solutions enable collaboration across and within organizations to make sense of large and complex data sets. Palantir serves government, defense, finance, healthcare, and other industries. The company was founded in 2003 and is based in Palo Alto, California.

LookSharp

Series A in 2013
LookSharp is an online platform designed to connect students with companies seeking interns, thereby enhancing the college hiring process. Founded in 2009 by Andrew Maguire and Nathan Parcells, the platform originally operated in Washington but expanded nationally by 2011. LookSharp provides a Campus Hub product that showcases companies year-round through rich content, helping students make informed decisions about their applications. The platform simplifies the internship search and application process, allowing users to discover opportunities without registration, and offers skill-based matching recommendations. Additionally, LookSharp maintains a resource library for students and organizations, featuring tools for resume creation and internship preparation, as well as advice for managing internship programs. The platform emphasizes the importance of socially responsible positions, enabling students to seek experiential learning opportunities that combine career development with positive social impact. With over 10 million users, LookSharp aims to facilitate meaningful connections between students and employers.

Versa Networks

Series A in 2012
Versa Networks, Inc. is a technology company specializing in software-defined networking (SDN) and cybersecurity solutions. Established in 2012 and headquartered in Santa Clara, California, with an additional office in Bengaluru, India, Versa focuses on providing integrated cloud, networking, and security services for enterprise and service provider customers. The company’s offerings include advanced secure access service edge (SASE) solutions that combine networking, security, and analytics, delivered through cloud, on-premises, or hybrid models. Versa's platform is designed for scalability, featuring genuine multitenancy and sophisticated management tools that help organizations optimize their wide area networks (WAN) and reduce infrastructure costs. With thousands of customers worldwide, Versa Networks is committed to simplifying and securing modern networks across a diverse range of environments.

Nimble Storage

Series E in 2012
Nimble Storage, Inc. specializes in providing flash storage platforms designed to enhance the performance of various business applications. The company's offerings include InfoSight, a predictive cloud platform that integrates predictive analytics with flash storage and multicloud infrastructure, streamlining operations in both on-premises data centers and cloud environments. Nimble Storage's product line features AF-Series All Flash arrays and CS-Series Adaptive Flash arrays, which are optimized for high-I/O applications such as Oracle and SQL Server. Additionally, Nimble Cloud Volumes deliver an enterprise-grade multi-cloud storage solution that supports applications in major cloud environments like Amazon Web Services and Microsoft Azure. The company markets its products through a network of value-added resellers, system integrators, and distributors across diverse sectors, including healthcare, education, financial services, and technology. Founded in 2007 and headquartered in San Jose, California, Nimble Storage operates as a subsidiary of Hewlett Packard Enterprise Company.

ClearEdge Power

Series E in 2011
ClearEdge Power is a provider of clean and secure energy solutions, specializing in onsite energy generation systems suitable for residential and small commercial applications. The company offers compact power and heat energy systems ranging from 5 kW to multiple megawatts, designed to deliver backup power for essential devices like refrigerators, freezers, electronics, and computers. With a focus on innovative fuel cell technology, ClearEdge Power aims to help customers reduce electricity costs, enhance energy efficiency, and lower carbon emissions. Its expertise as a leading fuel cell producer positions ClearEdge Power as a transformative force in the energy sector.

Quid

Series C in 2011
Quid, Inc. is a technology company based in San Francisco, California, with additional offices in New York and London. Founded in 2006, Quid develops a platform that enables users to search, analyze, and visualize collective intelligence derived from written language. Its software specializes in text-based data analysis, utilizing artificial intelligence and natural language processing to uncover insights from vast datasets, including patents, news articles, and blog posts. Quid's proprietary algorithms facilitate the identification of patterns and connections, allowing non-technical users in various sectors, such as marketing, consulting, technology, healthcare, and finance, to independently access and derive meaningful insights from high-value information. In January 2020, Quid merged with NetBase Solutions, forming a combined entity known as Netbase Quid.

Nimble Storage

Series D in 2011
Nimble Storage, Inc. specializes in providing flash storage platforms designed to enhance the performance of various business applications. The company's offerings include InfoSight, a predictive cloud platform that integrates predictive analytics with flash storage and multicloud infrastructure, streamlining operations in both on-premises data centers and cloud environments. Nimble Storage's product line features AF-Series All Flash arrays and CS-Series Adaptive Flash arrays, which are optimized for high-I/O applications such as Oracle and SQL Server. Additionally, Nimble Cloud Volumes deliver an enterprise-grade multi-cloud storage solution that supports applications in major cloud environments like Amazon Web Services and Microsoft Azure. The company markets its products through a network of value-added resellers, system integrators, and distributors across diverse sectors, including healthcare, education, financial services, and technology. Founded in 2007 and headquartered in San Jose, California, Nimble Storage operates as a subsidiary of Hewlett Packard Enterprise Company.

Practice Fusion

Series B in 2011
Practice Fusion, Inc. is a cloud-based electronic health records (EHR) company based in San Francisco, California, founded in 2005. The company specializes in providing a comprehensive practice management software platform that facilitates various healthcare functions, including charting, scheduling, billing, e-prescribing, lab integrations, and secure messaging. By connecting doctors, patients, and data, Practice Fusion aims to enhance healthcare delivery and improve patient outcomes. Its platform serves a diverse range of users, including independent medical practices, large medical groups, and community clinics, as well as life science partners. Additionally, Practice Fusion Insight offers a healthcare database to support medical professionals in their practice. As of February 2018, Practice Fusion operates as a subsidiary of Allscripts Healthcare Solutions, Inc.

Stemcentrx

Series C in 2011
Stemcentrx is a biotechnology company focused on developing innovative therapies aimed at curing cancer and improving patient survival rates. Founded in 2008 by Brian Slingerland and Scott J. Dylla, the company is headquartered in South San Francisco, California. Stemcentrx specializes in creating disease-specific treatments that target cancer stem cells, the cells responsible for initiating and sustaining tumor growth. This approach allows healthcare providers to more effectively address the root causes of cancer, enhancing the potential for successful outcomes for patients. In 2016, Stemcentrx became a subsidiary of AbbVie, further expanding its resources and capabilities in the fight against cancer.

Tilera

Series D in 2011
Tilera Corporation is a fabless semiconductor company based in San Jose, California, with additional locations in Westborough, Massachusetts, and Beijing, China. Founded in 2004, Tilera specializes in designing multicore embedded processors tailored for networking, digital multimedia, and wireless infrastructure markets. The company's product portfolio includes the TILEPro multicore processor, which is designed to deliver high-performance computing for various embedded applications such as networking, wireless infrastructure, and digital multimedia processing. Additionally, Tilera offers a multicore development environment for programming solutions and TILExpress PCIe production cards.

Oorja Fuel Cells

Debt Financing in 2010
Oorja Fuel Cells, founded in 2004 in Silicon Valley, is a global energy company focused on advancing the methanol economy through the design, development, and commercialization of Direct Methanol Fuel Cells (DMFCs). These fuel cells, which range in power from 0.5 to 100 kilowatts, are applicable across various industries, including telecommunications, transportation, distributed energy, and microgrids. Oorja's technology combines the advantages of fuel cells and traditional batteries to deliver high-power solutions that significantly lower operating costs and greenhouse gas emissions. The company serves diverse sectors such as original equipment manufacturers, logistics providers, automotive manufacturers, and food processing companies, helping them to reduce their environmental impact by minimizing harmful gas emissions.

VUDU

Series C in 2008
VUDU, Inc. is a digital entertainment company that specializes in delivering Internet-based streaming services for movies and television shows. The company operates an online platform that provides a vast library of content accessible through various devices, including HDTVs, Blu-ray players, and gaming consoles, allowing users to enjoy their favorite shows without the need for subscriptions or contracts. VUDU offers a range of products, including the VUDU Box and VUDU XL, which facilitate access to its streaming services, as well as accessories like replacement remotes and power supplies. The company collaborates with movie studios, independent filmmakers, and distributors to curate its offerings, making its services available through authorized installers and online channels. Formerly known as Marquee, Inc., VUDU continues to innovate in the digital entertainment space.

Dash Navigation

Series C in 2008
Dash Navigation has plans to change your automotive GPS units for good by bringing maps mashups as well as internet capability. Unlike today's car GPS units which necessitate extra downloads to update map changes, add features or otherwise, Dash Navigation updates and extra features will all come via web connection in real time. The device will be connected through a cellular data network and will also sport WiFi connectivity. The device will collect data about traffic conditions from all other Dash drivers, and estimates how long alternative routes will take on any given day. All sorts of geo-tagged information can be pushed to the device and combined with the on-board maps. Everything from restaurants and open houses to concerts, gas, and golf courses could be sent to the Dash and appear there on your screen. Owners will be able to manage which mashups they receive through Dash's Website. There, they will be able to drag feeds from sites like [Platial](http://crunchbase.com/organization/platial), where they can create a Google Map of dog runs in San Francisco or yoga schools in LA. Link it to [Zillow](http://crunchbase.com/organization/zillow), and you will be able to get data on houses as you are driving around the neighborhood. Create a feed at Upcoming.org about all the rock concerts in your city or one of open houses from Craigslist, and you will be able to get the info in your car, along with how far away each place is. You will also be able to do a Yahoo Local search on the device for restaurants and it will return nearby results with ratings. The company is backed by both VC powerhouses, Sequoia Capital and Kleiner Perkins as well as a slew of others.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.